top of page

The Growth of Biosimilars Continues to Create Hope for Lower Drug Costs

  • Aug 27, 2023
  • 1 min read

Before a once-in-a-generation pandemic struck the globe, adalimumab (Humira; AbbVie) was the most profitable drug in the world...



 
 
bottom of page